CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYCR) today announced the addition of industry leader Clint H. Severson to its Board of Directors, one of a series of key executive moves driving the late-stage bio-scientific research company’s move toward broad distribution of its line of products for the early detection and treatment of reproductive cancers.
